Join the Weight Loss (Obesity / Overweight) group to help and get support from people like you.
Weight Loss (Obesity / Overweight) News (Page 24)
Related terms: Weight Gain, Overweight, Weightloss, Anorexiants, Obesity, Obese, Weight Loss, Loose Weight, Lost Weight, diet drugs, diet medications, anti-obesity medications, Weight Loss Medications
Widening Disparities Seen in Youth Obesity
WEDNESDAY, May 15, 2024 – In the 2019 to 2020 school year, 20.9 percent of New York City elementary and middle school students had obesity, and 6.4 percent had severe obesity, according to a study...
For Women With Obesity, Risk for Breast Cancer Drops After Bariatric Surgery
THURSDAY, May 16, 2024 – For women with obesity, the risk for breast cancer is reduced after bariatric surgery, according to a study published online May 15 in JAMA Surgery. Felipe M. Kristensson,...
Childhood Weight Status May Stratify Mortality Risk in Adults With Obesity
THURSDAY, May 16, 2024 – In adults with obesity, childhood weight status may stratify mortality risk, according to a study presented at the annual meeting of the European Congress on Obesity, hosted...
Activity Tracker, Scale Plus Phone App May Aid Weight Loss
THURSDAY, May 16, 2024 – Weight loss is similar for individuals using a wireless feedback system (WFS) that provides daily information on lifestyle change and weight loss versus the same system...
Four in 10 Adults With Diabetes Report Taking a GLP-1 Receptor Agonist
TUESDAY, May 14, 2024 – One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, according to...
One Key to Weight Loss for Men: Competing for Cash
WEDNESDAY, May 15, 2024 – A competitive game with a potential cash reward appeared to help overweight British men lose weight, researchers report. The incentive was winning the "Game of Stones" – a...
GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription
WEDNESDAY, May 15, 2024 – Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a study published...
Text Messages + Financial Incentives Boost Weight Loss at 12 Months
WEDNESDAY, May 15, 2024 – Among men with obesity, an intervention with text messaging plus financial incentive significantly improves weight loss compared with a control group, according to a study...
Smoking During Pregnancy Could Raise Baby's Odds for Obesity Later
TUESDAY, May 14, 2024 – Women who smoke during pregnancy run a higher risk of their kids becoming overweight or obese, and researchers now think they know one reason why. Children born of moms who...
More Studies Support Wegovy's Long-Term Weight-Loss Benefits
TUESDAY, May 14, 2024 – Semaglutide – the active ingredient in the blockbuster weight-loss drugs Ozempic and Wegovy – can produce long-term weight and heart health benefits, a pair of new studies...
Most Slow Responders to Tirzepatide Do Lose Clinically Meaningful Weight
TUESDAY, May 14, 2024 – Among slow responders to tirzepatide treatment at week 12, 90 percent went on to achieve clinically meaningful weight reduction (≥5 percent) by week 72, according to a study p...
Wegovy Approved in the US for Cardiovascular Risk Reduction in People with Overweight or Obesity and Established Cardiovascular Disease
Bagsværd, Denmark, 8 March 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy based on a supplemental New Drug Application (s...
A Cardiologist Answers Your Questions on New Weight-Loss Meds, Ozempic and Zepbound
MONDAY, Feb. 12, 2024 – Weight loss drugs like Ozempic and Zepbound can lead to better heart health for people struggling with excess weight or diabetes, a University of Michigan cardiologist says....
A Cardiologist Answers Your Questions on New Weight-Loss Meds, Ozempic and Zepbound
MONDAY, Feb. 12, 2024 – Weight loss drugs like Ozempic and Zepbound can lead to better heart health for people struggling with excess weight or diabetes, a University of Michigan cardiologist says....
FDA Approves Zepbound (tirzepatide) for Chronic Weight Management
INDIANAPOLIS, Nov. 8, 2023 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's (NYSE: LLY) Zepbound™ (tirzepatide) injection, the first and only obesity t...
Further information
Related drug support groups
bupropion, phentermine, Contrave, Ozempic, amphetamine, Saxenda, methamphetamine, Mounjaro, topiramate, view more... Wegovy, semaglutide, methylphenidate, Qsymia, Zepbound, liraglutide, Adipex-P, tirzepatide, Alli, orlistat, garcinia cambogia, desvenlafaxine, dulaglutide